← SynDRA
TEMOZOLOMIDE
SynDRA canonical compound SYN0001973 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | MGMT |
|---|
| Mechanism of action | DNA alkylating agent |
|---|
| Indication | astrocytoma | glioblastoma |
|---|
| Disease area | oncology |
|---|
All known targets
Mechanisms of action (all sources)
Drug classes
- Alkylating Activity
- Alkylating Drug
- Alkylating Agents
- Antineoplastic Agents
- Antineoplastic Agents, Alkylating
- Noxae
ATC classes
Cross-references
Synonyms
- temomedac
- SCH 52365
- methazolastone
- temodal
- temozolamide
- Temozolomida
- Methazolastone
- Mk-7365
- CCRG-81045
- M&B-39831
- M-39831
- NSC-362856
- SCH-52365
- Temodal
- Temodar
- Temomedac
- Temozolomide accord
- Temozolomide hexal
- Temozolomide sandoz
- Temozolomide sun
- Temozolomide teva
- Temozolamide
- Temozolodida
- Temozolomidum
- Essex brand of temozolomide
- Scheringbrand of temozolomide
- Temozolodida [Spanish]
- Temozolomidum [Latin]
- M B 39831
- MB 39831
- Sch-52365
- M & B 39831
- Schering-Plough brand of temozolomide
- TMZ-Bioshuttle
- Temodal (TN)
- Temodar (TN)
- Temozolomide [INN:BAN]
- Temozolomide (JAN/USAN/INN)
Reported adverse events
- Myelosuppression
- Diabetes insipidus
- Fatigue
- Infection
- Rash
- Toxic epidermal necrolysis
- Stevens-Johnson syndrome
- Ataxia
- Erythema
- Stomatitis
- Opportunistic infection
- Erythema multiforme
Look up TEMOZOLOMIDE in the interactive SynDRA portal →